Which has better earnings and valuation, RGEN or DHR?

Danaher has higher revenue and earnings than Repligen. Danaher is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Repligen $738.26M 10.88 $48.89M $0.90 158.22 Danaher $24.78B 5.65 $3.61B $5.17 38.27

Is RGEN or DHR more profitable?

Danaher has a net margin of 14.89% compared to Repligen's net margin of 6.73%. Danaher's return on equity of 10.91% beat Repligen's return on equity. Company Net Margins Return on Equity Return on Assets Repligen 6.73% 4.88% 3.48% Danaher 14.89% 10.91% 6.94%

Does the media favor RGEN or DHR?

In the previous week, Danaher had 11 more articles in the media than Repligen. MarketBeat recorded 14 mentions for Danaher and 3 mentions for Repligen. Danaher's average media sentiment score of 0.89 beat Repligen's score of 0.24 indicating that Danaher is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repligen 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Danaher 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, DHR or TECH?

Danaher has higher revenue and earnings than Bio-Techne. Danaher is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Danaher $24.78B 5.65 $3.61B $5.17 38.27 Bio-Techne $1.21B 9.16 $73.40M $0.69 102.65

Is DHR or TECH more profitable?

Danaher has a net margin of 14.89% compared to Bio-Techne's net margin of 9.05%. Bio-Techne's return on equity of 13.57% beat Danaher's return on equity. Company Net Margins Return on Equity Return on Assets Danaher 14.89% 10.91% 6.94% Bio-Techne 9.05% 13.57% 10.66%

Does the media prefer DHR or TECH?

In the previous week, Danaher had 7 more articles in the media than Bio-Techne. MarketBeat recorded 14 mentions for Danaher and 7 mentions for Bio-Techne. Danaher's average media sentiment score of 0.89 beat Bio-Techne's score of 0.70 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Techne 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to DHR or A?

In the previous week, Danaher had 9 more articles in the media than Agilent Technologies. MarketBeat recorded 14 mentions for Danaher and 5 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.33 beat Danaher's score of 0.89 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, DHR or CR?

Danaher has higher revenue and earnings than Crane. Danaher is trading at a lower price-to-earnings ratio than Crane, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Danaher $24.78B 5.65 $3.61B $5.17 38.27 Crane $2.44B 5.15 $401.10M $5.56 39.18

Is DHR or CR more profitable?

Danaher has a net margin of 14.89% compared to Crane's net margin of 13.10%. Crane's return on equity of 24.45% beat Danaher's return on equity. Company Net Margins Return on Equity Return on Assets Danaher 14.89% 10.91% 6.94% Crane 13.10% 24.45% 10.14%

Does the media refer more to DHR or CR?

In the previous week, Crane had 6 more articles in the media than Danaher. MarketBeat recorded 20 mentions for Crane and 14 mentions for Danaher. Danaher's average media sentiment score of 0.89 beat Crane's score of 0.46 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Crane 5 Very Positive mention(s) 4 Positive mention(s) 9 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, DHR or CSL?

Danaher has higher revenue and earnings than Carlisle Companies. Carlisle Companies is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Danaher $24.78B 5.65 $3.61B $5.17 38.27 Carlisle Companies $5.02B 2.95 $740.70M $17.01 21.54

Does the media favor DHR or CSL?

In the previous week, Danaher had 9 more articles in the media than Carlisle Companies. MarketBeat recorded 14 mentions for Danaher and 5 mentions for Carlisle Companies. Danaher's average media sentiment score of 0.89 beat Carlisle Companies' score of 0.53 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Carlisle Companies 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Danaher (DHR) Competitors

$197.85 -0.08 (-0.04%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$197.74 -0.10 (-0.05%)

As of 07/2/2026 07:52 PM Eastern

Compare

DHR vs. RGEN, TECH, A, CR, and CSL

Should you buy Danaher stock or one of its competitors? MarketBeat compares Danaher with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Danaher include Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), Crane (CR), and Carlisle Companies (CSL).

How does Danaher compare to Repligen?

Repligen (NASDAQ:RGEN) and Danaher (NYSE:DHR) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

In the previous week, Danaher had 11 more articles in the media than Repligen. MarketBeat recorded 14 mentions for Danaher and 3 mentions for Repligen. Danaher's average media sentiment score of 0.89 beat Repligen's score of 0.24 indicating that Danaher is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repligen	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Danaher	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Danaher has higher revenue and earnings than Repligen. Danaher is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repligen	$738.26M	10.88	$48.89M	$0.90	158.22
Danaher	$24.78B	5.65	$3.61B	$5.17	38.27

Repligen currently has a consensus target price of $164.64, suggesting a potential upside of 15.62%. Danaher has a consensus target price of $233.61, suggesting a potential upside of 18.08%. Given Danaher's higher possible upside, analysts clearly believe Danaher is more favorable than Repligen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repligen	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.88
Danaher	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.80

97.6% of Repligen shares are held by institutional investors. Comparatively, 79.1% of Danaher shares are held by institutional investors. 0.6% of Repligen shares are held by insiders. Comparatively, 10.8% of Danaher shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Repligen has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market. Comparatively, Danaher has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market.

Danaher has a net margin of 14.89% compared to Repligen's net margin of 6.73%. Danaher's return on equity of 10.91% beat Repligen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repligen	6.73%	4.88%	3.48%
Danaher	14.89%	10.91%	6.94%

Summary

Danaher beats Repligen on 11 of the 17 factors compared between the two stocks.

How does Danaher compare to Bio-Techne?

Danaher (NYSE:DHR) and Bio-Techne (NASDAQ:TECH) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

79.1% of Danaher shares are owned by institutional investors. Comparatively, 98.9% of Bio-Techne shares are owned by institutional investors. 10.8% of Danaher shares are owned by insiders. Comparatively, 1.3% of Bio-Techne shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Danaher had 7 more articles in the media than Bio-Techne. MarketBeat recorded 14 mentions for Danaher and 7 mentions for Bio-Techne. Danaher's average media sentiment score of 0.89 beat Bio-Techne's score of 0.70 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Techne	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Danaher has higher revenue and earnings than Bio-Techne. Danaher is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.78B	5.65	$3.61B	$5.17	38.27
Bio-Techne	$1.21B	9.16	$73.40M	$0.69	102.65

Danaher presently has a consensus target price of $233.61, indicating a potential upside of 18.08%. Bio-Techne has a consensus target price of $67.79, indicating a potential downside of 4.30%. Given Danaher's stronger consensus rating and higher possible upside, equities research analysts plainly believe Danaher is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.80
Bio-Techne	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33

Danaher has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market. Comparatively, Bio-Techne has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market.

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.8%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Danaher pays out 30.9% of its earnings in the form of a dividend. Bio-Techne pays out 46.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has raised its dividend for 2 consecutive years. Danaher is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Danaher has a net margin of 14.89% compared to Bio-Techne's net margin of 9.05%. Bio-Techne's return on equity of 13.57% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	14.89%	10.91%	6.94%
Bio-Techne	9.05%	13.57%	10.66%

Summary

Danaher beats Bio-Techne on 13 of the 19 factors compared between the two stocks.

How does Danaher compare to Agilent Technologies?

Danaher (NYSE:DHR) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.8%. Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.8%. Danaher pays out 30.9% of its earnings in the form of a dividend. Agilent Technologies pays out 20.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has raised its dividend for 2 consecutive years and Agilent Technologies has raised its dividend for 9 consecutive years.

Danaher has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.78B	5.65	$3.61B	$5.17	38.27
Agilent Technologies	$6.95B	5.32	$1.30B	$4.98	26.26

Danaher presently has a consensus price target of $233.61, suggesting a potential upside of 18.08%. Agilent Technologies has a consensus price target of $160.88, suggesting a potential upside of 23.01%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Agilent Technologies is more favorable than Danaher.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.80
Agilent Technologies	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.94

79.1% of Danaher shares are owned by institutional investors. 10.8% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Agilent Technologies has a net margin of 19.55% compared to Danaher's net margin of 14.89%. Agilent Technologies' return on equity of 24.33% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	14.89%	10.91%	6.94%
Agilent Technologies	19.55%	24.33%	12.99%

Danaher has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

In the previous week, Danaher had 9 more articles in the media than Agilent Technologies. MarketBeat recorded 14 mentions for Danaher and 5 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.33 beat Danaher's score of 0.89 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilent Technologies	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Danaher and Agilent Technologies tied by winning 10 of the 20 factors compared between the two stocks.

How does Danaher compare to Crane?

Danaher (NYSE:DHR) and Crane (NYSE:CR) are related large-cap companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

79.1% of Danaher shares are owned by institutional investors. Comparatively, 75.1% of Crane shares are owned by institutional investors. 10.8% of Danaher shares are owned by insiders. Comparatively, 2.1% of Crane shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Danaher presently has a consensus target price of $233.61, suggesting a potential upside of 18.08%. Crane has a consensus target price of $226.33, suggesting a potential upside of 3.91%. Given Danaher's higher possible upside, research analysts clearly believe Danaher is more favorable than Crane.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.80
Crane	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.13

Danaher has higher revenue and earnings than Crane. Danaher is trading at a lower price-to-earnings ratio than Crane, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.78B	5.65	$3.61B	$5.17	38.27
Crane	$2.44B	5.15	$401.10M	$5.56	39.18

Danaher has a net margin of 14.89% compared to Crane's net margin of 13.10%. Crane's return on equity of 24.45% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	14.89%	10.91%	6.94%
Crane	13.10%	24.45%	10.14%

In the previous week, Crane had 6 more articles in the media than Danaher. MarketBeat recorded 20 mentions for Crane and 14 mentions for Danaher. Danaher's average media sentiment score of 0.89 beat Crane's score of 0.46 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Crane	5 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.8%. Crane pays an annual dividend of $1.02 per share and has a dividend yield of 0.5%. Danaher pays out 30.9% of its earnings in the form of a dividend. Crane pays out 18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has increased its dividend for 2 consecutive years and Crane has increased its dividend for 3 consecutive years.

Danaher has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Crane has a beta of 1, meaning that its share price has a similar volatility profile to the broader market.

Summary

Danaher beats Crane on 11 of the 20 factors compared between the two stocks.

How does Danaher compare to Carlisle Companies?

Danaher (NYSE:DHR) and Carlisle Companies (NYSE:CSL) are both large-cap industrial conglomerates companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership, profitability and media sentiment.

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.8%. Carlisle Companies pays an annual dividend of $4.40 per share and has a dividend yield of 1.2%. Danaher pays out 30.9% of its earnings in the form of a dividend. Carlisle Companies pays out 25.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has raised its dividend for 2 consecutive years and Carlisle Companies has raised its dividend for 48 consecutive years. Carlisle Companies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Danaher has a net margin of 14.89% compared to Carlisle Companies' net margin of 14.57%. Carlisle Companies' return on equity of 43.78% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	14.89%	10.91%	6.94%
Carlisle Companies	14.57%	43.78%	13.66%

79.1% of Danaher shares are held by institutional investors. Comparatively, 89.5% of Carlisle Companies shares are held by institutional investors. 10.8% of Danaher shares are held by company insiders. Comparatively, 1.3% of Carlisle Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Danaher had 9 more articles in the media than Carlisle Companies. MarketBeat recorded 14 mentions for Danaher and 5 mentions for Carlisle Companies. Danaher's average media sentiment score of 0.89 beat Carlisle Companies' score of 0.53 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Carlisle Companies	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Danaher has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Carlisle Companies has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

Danaher currently has a consensus target price of $233.61, suggesting a potential upside of 18.08%. Carlisle Companies has a consensus target price of $405.00, suggesting a potential upside of 10.54%. Given Danaher's stronger consensus rating and higher probable upside, research analysts clearly believe Danaher is more favorable than Carlisle Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.80
Carlisle Companies	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

Danaher has higher revenue and earnings than Carlisle Companies. Carlisle Companies is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.78B	5.65	$3.61B	$5.17	38.27
Carlisle Companies	$5.02B	2.95	$740.70M	$17.01	21.54

Summary

Danaher beats Carlisle Companies on 12 of the 20 factors compared between the two stocks.

Get Danaher News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DHR vs. The Competition

Export

Metric	Danaher	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$140.09B	$9.63B	$7.16B	$23.53B
Dividend Yield	0.81%	1.62%	2.66%	3.98%
P/E Ratio	38.27	27.84	28.02	31.55
Price / Sales	5.65	18.50	540.37	21.06
Price / Cash	17.41	114.69	49.26	25.36
Price / Book	2.66	6.19	10.96	4.81
Net Income	$3.61B	$179.69M	$3.57B	$1.07B
7 Day Performance	1.11%	3.82%	2.12%	0.56%
1 Month Performance	7.26%	10.36%	5.25%	4.54%
1 Year Performance	-2.57%	14.53%	33.29%	18.23%

Danaher Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DHR Danaher	4.5298 of 5 stars	$197.85 0.0%	$233.61 +18.1%	-2.6%	$140.09B	$24.78B	38.27	60,000
RGEN Repligen	3.3505 of 5 stars	$125.65 -0.7%	$164.64 +31.0%	+11.8%	$7.09B	$738.26M	139.61	2,000
TECH Bio-Techne	1.8227 of 5 stars	$56.40 +1.4%	$65.15 +15.5%	+33.3%	$8.83B	$1.21B	81.74	3,100	Analyst Downgrade
A Agilent Technologies	4.9087 of 5 stars	$127.07 +0.5%	$160.93 +26.6%	+7.9%	$35.89B	$6.95B	25.52	18,100	Ex-Dividend
CR Crane	3.8509 of 5 stars	$214.61 -0.2%	$226.33 +5.5%	+12.8%	$12.39B	$2.44B	28.43	11,000	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DHR) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Danaher (DHR) Competitors